The Patent Finder

MDNA Life Sciences Inc.

Also on record
Records under this name other than the patents MDNA Life Sciences Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Showing 1 to 4 of 4 · Back to MDNA Life Sciences Inc.

PatentTitleStatus Expires Confidence
US 11,111,5463.4 KB mitochondrial DNA deletion for use in the detection of cancer
Term ended
Term ended Sep 1, 2026 · From the USPTO record
Term endedTerm ended Sep 1, 2026From the USPTO record
US 10,308,9873.4 kb mitochondrial DNA deletion for use in the detection of cancer
Term ended
Ended no later than Apr 18, 2026 · From the USPTO record
Term endedEnded no later than Apr 18, 2026From the USPTO record
US 8,715,960Aberrant mitochondrial DNA, associated fusion transcripts and translation products and hybridization probes therefor
Lapsed on the fee record
Ended May 6, 2022 · From the USPTO record
Lapsed on the fee recordEnded May 6, 2022From the USPTO record
US 9,745,632Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
Lapsed on the fee record
Ended Aug 29, 2021 · From the USPTO record
Lapsed on the fee recordEnded Aug 29, 2021From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited